147 related articles for article (PubMed ID: 19308286)
1. Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment.
Yang Y; Zhao Y; Liao W; Yang J; Wu L; Zheng Z; Yu Y; Zhou W; Li L; Feng J; Wang H; Zhu WG
Neoplasia; 2009 Apr; 11(4):313-24. PubMed ID: 19308286
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.
Zhao Y; Tan J; Zhuang L; Jiang X; Liu ET; Yu Q
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16090-5. PubMed ID: 16243973
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms.
De Bruyne E; Bos TJ; Schuit F; Van Valckenborgh E; Menu E; Thorrez L; Atadja P; Jernberg-Wiklund H; Vanderkerken K
Blood; 2010 Mar; 115(12):2430-40. PubMed ID: 20086250
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin C Synergistically Interacts with DNMT Inhibitor to Induce Antineoplastic Effect via Inhibition of Axl in Bladder and Lung Cancer Cells.
Wang C; Lei L; Xu Y; Li Y; Zhang J; Xu Y; Si S
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675387
[TBL] [Abstract][Full Text] [Related]
5. The regulation of FOXO1 and its role in disease progression.
Xing YQ; Li A; Yang Y; Li XX; Zhang LN; Guo HC
Life Sci; 2018 Jan; 193():124-131. PubMed ID: 29158051
[TBL] [Abstract][Full Text] [Related]
6. Yunpi Heluo decoction attenuates insulin resistance by regulating SIRT1-FoxO1 autophagy pathway in skeletal muscle of Zucker diabetic fatty rats.
Mao ZJ; Xia WS; Chai F
J Ethnopharmacol; 2021 Apr; 270():113828. PubMed ID: 33476712
[TBL] [Abstract][Full Text] [Related]
7. Deacetylation of FoxO by Sirt1 Plays an Essential Role in Mediating Starvation-Induced Autophagy in Cardiac Myocytes.
Hariharan N; Maejima Y; Nakae J; Paik J; Depinho RA; Sadoshima J
Circ Res; 2010 Dec; 107(12):1470-82. PubMed ID: 20947830
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Potential of Natural Products as FoxO1 Inhibitors: an
Gupta A; Haldhar R; Agarwal V; Rajput DS; Chun KS; Han SB; Raj V; Lee S
Biomol Ther (Seoul); 2024 May; 32(3):390-398. PubMed ID: 38586882
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of FOXO1 activates Bim expression involved in CVB3 induced cardiomyocyte apoptosis.
Hu Y; Yi L; Yang Y; Wu Z; Kong M; Kang Z; Yang Z
Apoptosis; 2023 Dec; ():. PubMed ID: 38127284
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid treatment attenuates cisplatin-induced kidney injury by suppressing proximal tubular cell damage.
Yoshioka T; Goda M; Kanda M; Itobayashi S; Sugimoto Y; Izawa-Ishizawa Y; Yagi K; Aizawa F; Miyata K; Niimura T; Hamano H; Sakurada T; Zamami Y; Ishizawa K
Clin Transl Sci; 2023 Nov; 16(11):2369-2381. PubMed ID: 37700528
[TBL] [Abstract][Full Text] [Related]
11. KAT8 acetylation-controlled lipolysis affects the invasive and migratory potential of colorectal cancer cells.
Qiu B; Li S; Li M; Wang S; Mu G; Chen K; Wang M; Zhu WG; Wang W; Wang J; Li Z; Yang J; Yang Y
Cell Death Dis; 2023 Feb; 14(2):164. PubMed ID: 36849520
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitor SAHA Induces Expression of Fatty Acid-Binding Protein 4 and Inhibits Replication of Human Cytomegalovirus.
Liu Z; Xuan B; Tang S; Qian Z
Virol Sin; 2021 Dec; 36(6):1352-1362. PubMed ID: 34156645
[TBL] [Abstract][Full Text] [Related]
13. Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance.
Li GH; Qu Q; Qi TT; Teng XQ; Zhu HH; Wang JJ; Lu Q; Qu J
J Exp Clin Cancer Res; 2021 May; 40(1):174. PubMed ID: 34011395
[TBL] [Abstract][Full Text] [Related]
14. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.
Li G; Tian Y; Zhu WG
Front Cell Dev Biol; 2020; 8():576946. PubMed ID: 33117804
[TBL] [Abstract][Full Text] [Related]
15. Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development.
Burrows N; Bashford-Rogers RJM; Bhute VJ; Peñalver A; Ferdinand JR; Stewart BJ; Smith JEG; Deobagkar-Lele M; Giudice G; Connor TM; Inaba A; Bergamaschi L; Smith S; Tran MGB; Petsalaki E; Lyons PA; Espeli M; Huntly BJP; Smith KGC; Cornall RJ; Clatworthy MR; Maxwell PH
Nat Immunol; 2020 Nov; 21(11):1408-1420. PubMed ID: 32868930
[TBL] [Abstract][Full Text] [Related]
16. The pseudo-caspase FLIP(L) regulates cell fate following p53 activation.
Lees A; McIntyre AJ; Crawford NT; Falcone F; McCann C; Holohan C; Quinn GP; Roberts JZ; Sessler T; Gallagher PF; Gregg GMA; McAllister K; McLaughlin KM; Allen WL; Egan LJ; Ryan AE; Labonte-Wilson MJ; Dunne PD; Wappett M; Coyle VM; Johnston PG; Kerr EM; Longley DB; McDade SS
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17808-17819. PubMed ID: 32661168
[TBL] [Abstract][Full Text] [Related]
17. Uev1A promotes breast cancer cell survival and chemoresistance through the AKT-FOXO1-BIM pathway.
Wu Z; Niu T; Xiao W
Cancer Cell Int; 2019; 19():331. PubMed ID: 31827405
[TBL] [Abstract][Full Text] [Related]
18. Appoptosin Mediates Lesions Induced by Oxidative Stress Through the JNK-FoxO1 Pathway.
Zhang C; Tan Z; Xie Y; Zhao Y; Huang TY; Lu Z; Luo H; Can D; Xu H; Zhang YW; Zhang X
Front Aging Neurosci; 2019; 11():243. PubMed ID: 31551758
[TBL] [Abstract][Full Text] [Related]
19. Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer.
Sánchez-Álvarez M; Strippoli R; Donadelli M; Bazhin AV; Cordani M
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31546746
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
